Provenance du réseau au premier degré de Masanobu Ogawa
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Maruho Israel Innovation Fund
 Maruho Israel Innovation Fund Financial ConglomeratesFinance Maruho Israel Innovation Fund engages in investments in dermatology-related technologies, biotech, medical devices, digital health, and cosmetics. The company was founded by Junichi Hamada, Eran Perry, Doron Friedman, and Masanobu Ogawa in 2018 and is headquartered in Rehovot, Israel.
5
| Private Company | Financial Conglomerates | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Masanobu Ogawa via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| COMPUGEN LTD. | Biotechnology | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
I.H.C.V Israel Healthcare Ventures Ltd.
 I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures Ltd. (Israel Healthcare Ventures) is a venture capital firm founded in 2000 by Hadar Ron. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree | |
| Weizmann Institute of Science | College/University | Graduate Degree | |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Pharmaceuticals: Major | Private Equity Analyst | |
Maruho Deutschland GmbH
 Maruho Deutschland GmbH Medical DistributorsDistribution Services Maruho Deutschland GmbH engages in the development, production, distribution, importation, and exportation of pharmaceutical and cosmetic products, medical devices, dietary supplements, and health food items. The company was founded on February 25, 2013 and is headquartered in Leverkusen, Germany. | Medical Distributors | Chief Executive Officer | |
| Columbia Business School | College/University | Masters Business Admin | |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
Elron Electronic Industries (venture capital)
 Elron Electronic Industries (venture capital) Investment ManagersFinance Elron Electronic Industries (venture capital) (Elron Electronic Industri) is a venture capital firm, a subsidiary of Elron Electronic Industries Ltd. founded in 2000. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Private Equity Investor | |
| Musli Thyropeutics Ltd. | Director/Board Member Founder | ||
| ICD Pharma Ltd. | Founder Founder Founder | ||
| Novartis Oncology | Sales & Marketing | ||
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Founder Founder | |
Noon Aesthetics Ltd.
 Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Noon Aesthetics Ltd. is an Israeli skincare company that focuses on science-based, clinically-proven solutions to enhance the beauty and health of skin. Noon Aesthetics is based in Tel Aviv, IL and was founded in 2012 by Eran Rosman and Masha Minkin. The private company is committed to research and innovation to ensure that their products deliver tangible results and improve the overall well-being of patients. The company's products include the Restart Serum, which helps to repair DNA damage caused by oxidative stress, UV rays, air pollution, pesticides, and aging. Eran Rosman has been the CEO since 2012. | Household/Personal Care | Director/Board Member | |
| Mckinsey & Co. /Israel/ | Private Equity Analyst |
Statistiques
Internationale
| Israël | 12 |
| Etats-Unis | 5 |
| Allemagne | 2 |
| Liban | 2 |
Sectorielle
| Consumer Services | 6 |
| Health Technology | 4 |
| Finance | 3 |
| Distribution Services | 2 |
| Commercial Services | 2 |
Opérationnelle
| Founder | 10 |
| Director/Board Member | 9 |
| Chief Executive Officer | 4 |
| Private Equity Investor | 3 |
| Private Equity Analyst | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Eran Perry | 13 |
| Earn Perry | 7 |
| Alona Weiss | 5 |
| Junichi Hamada | 2 |
| Doron Friedman | 2 |
- Bourse
- Insiders
- Masanobu Ogawa
- Connexions Sociétés
